Health IT

Spectrum Health's new Lowell facility isn't just another clinic; it's a strategic play to rewire recovery by integrating care in a state on high alert.

As NEXGEL prepares for a key investor conference, it faces a crucial test: convincing the market its advanced hydrogel tech can overcome recent financial hurdles.

A 2027 CMS mandate and AI pioneers like Humata Health are racing to fix prior authorization. But can technology truly untangle healthcare's notorious red tape?

Eli Lilly's partnership with cash-pay platform Sesame is more than a deal; it's a blueprint for a decentralized, direct-to-consumer healthcare market.

New data showing a 300% spike in demand for Burmese prescription translations is a stark economic signal of a deeper demographic shift challenging U.S. healthcare.

A new study reveals treating advanced gum disease has up to 10x the environmental impact of prevention, reframing sustainability from recycling to daily habits.

With record device sales providing a solid financial base, RenovoRx nears a critical milestone in its high-stakes Phase III trial for a new pancreatic cancer therapy.

Teva's new Eylea biosimilar hits Europe, a key move in its 'Pivot to Growth' strategy that promises to shake up the lucrative ophthalmology market.

A new U.S. launch challenges the solo-tracking norm in fertility tech. Soonr Health's dyadic platform and connected hormone device treat conception as a team sport.

The world's largest veterinary conference, VMX 2027, confronts industry burnout with its 'Off the Grid' theme, blending professional renewal with science.

As AI sweeps through medicine, Gigi Yuen-Reed's recognition highlights a crucial strategy: building systems that empower, not replace, human expertise.

With its first product launch, Daré Bioscience enters a new commercial era. But can a single probiotic launch secure the future of its ambitious pipeline?

GoHealth's third straight Georgia Fast 40 win isn't just an award; it's a signal. We dissect the 'connected care' model driving its explosive growth.

SciSparc's subsidiary just spent nearly C$10M on a quantum computing firm. This is the operational innovation designed to fix billion-dollar clinical trial failures.

A new diagnostic tool, Delve Detect, is using metagenomic sequencing to unmask elusive pathogens in the brain, offering hope where conventional tests fail.

A top Virginia cancer practice has been chosen to train US doctors in a breakthrough radiopharmaceutical therapy, a strategic move to break a key training bottleneck.

With an FDA decision just weeks away, Ionis's olezarsen could redefine care for a debilitating condition, marking a pivotal moment for RNA-targeted medicine.

As Insulet unveils pivotal data, a deeper look reveals a strategy to not just improve tech, but to fundamentally change the daily reality of diabetes.

The opening of a new eating disorder clinic is more than an expansion. It's a calculated response to a growing crisis and a model for strategic healthcare growth.

As security leaders prepare for the Gartner Summit, a new analyst watch list offers a roadmap to the AI-driven vendors and trends shaping the industry's bottom line.